Angelika Mühlebner
- Psychiatry and Mental health top 2%
- Epilepsy research and treatment 20
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders 5
-
- Pharmacological Effects and Toxicity Studies 8
-
- Neuroscience and Neuropharmacology Research 9
- Physiology top 5%
- Tuberous Sclerosis Complex Research 19
- Diet and metabolism studies 6
-
- Glioma Diagnosis and Treatment 8
- Genetics and Neurodevelopmental Disorders 7
- Co-authors
- Eleonora AronicaMartha FeuchtIngmar BlümckeGudrun GröppelAnastasia DresslerRoland CorasThomas CzechTheresa O. Scholl
- Partner nations
- NetherlandsAustriaItaly
In The Last Decade
Angelika Mühlebner
56 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 83
- Psychiatry and Mental health 792
- Clinical Biochemistry 214
- Pediatrics, Perinatology and Child Health 482
- Cellular and Molecular Neuroscience 394
- Physiology 514
Countries citing papers authored by Angelika Mühlebner
This map shows the geographic impact of Angelika Mühlebner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika Mühlebner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika Mühlebner more than expected).
Fields of papers citing papers by Angelika Mühlebner
This network shows the impact of papers produced by Angelika Mühlebner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika Mühlebner. The network helps show where Angelika Mühlebner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Angelika Mühlebner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 10 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 24 | |
| 10 | 2021 | 22 | |
| 11 | 2021 | 15 | |
| 12 | 2020 | 28 | |
| 13 | 2020 | 19 | |
| 14 | 2019 | 23 | |
| 15 | 2017 | 57 | |
| 16 | 2017 | 8 | |
| 17 | 2016 | 50 | |
| 18 | 2016 | 18 | |
| 19 | 2016 | 26 | |
| 20 | 2015 | 71 |
About Angelika Mühlebner
Angelika Mühlebner is a scholar working on Psychiatry and Mental health, Physiology and Genetics, having authored 59 papers that have together received 1.7k indexed citations. Recurring topics across this work include Epilepsy research and treatment (20 papers), Tuberous Sclerosis Complex Research (19 papers), Neuroscience and Neuropharmacology Research (9 papers), Glioma Diagnosis and Treatment (8 papers), Pharmacological Effects and Toxicity Studies (8 papers), Genetics and Neurodevelopmental Disorders (7 papers), Diet and metabolism studies (6 papers) and Metabolism and Genetic Disorders (5 papers). The work is most often cited by research in Psychiatry and Mental health (792 citations), Clinical Biochemistry (214 citations) and Pediatrics, Perinatology and Child Health (482 citations). Angelika Mühlebner has collaborated with scholars based in Netherlands, Austria and Italy. Frequent co-authors include Eleonora Aronica, Martha Feucht, Ingmar Blümcke, Gudrun Gröppel, Anastasia Dressler, Roland Coras, Thomas Czech, Theresa O. Scholl, Katja Kobow and Petra Trimmel‐Schwahofer. Their work appears in journals such as Nature Communications, Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.